Answer
The company Turing Pharmaceuticals, led by former CEO Martin Shkreli, gained notoriety in 2015 for drastically increasing the price of the life-saving drug Daraprim, a medication used to treat a parasitic infection called toxoplasmosis. The cost of a single pill was raised from $13.50 to $750 overnight, sparking widespread public outrage and scrutiny of the pharmaceutical industry's pricing practices.